Skip to main content

Advertisement

SpringerLink
Log in

State laws and prescribing rates of generic drugs in dermatology: a cross-sectional analysis of 2020 Medicare Part D claims data

  • RESEARCH LETTER
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mazmudar RS, Tripathi R, Bordeaux JS, Scott JF (2022) Trends in brand and generic drug utilization for dermatology providers from 2013–2019. Arch Dermatol Res. https://doi.org/10.1007/s00403-022-02431-2

    Article  PubMed  Google Scholar 

  2. Generic Pharmaceutical Association. Generic Drugs Continue to Deliver Billions in Savings to the U.S. Healthcare System, New Report Finds 2016. <http://www.prnewswire.com/news-releases/generic-drugs-continue-to-deliver-billions-in-savings-to-the-us-healthcare-system-new-report-finds-300347698.html/>. Accessed Jul 25, 2023

  3. Rome BN, Sarpatwari A, Kesselheim AS (2022) State laws and generic substitution in the year after new generic competition. Value Health 25(10):1736–1742. https://doi.org/10.1016/j.jval.2022.03.012. (Epub 2022 Apr 26. PMID: 35487821)

    Article  PubMed  Google Scholar 

  4. Bhatt MD, Bhatt BD, Dorrian JT, McLellan BN (2019) Increased topical generic prices by manufacturers. J Am Acad Dermatol 80(5):1353–1357. https://doi.org/10.1016/j.jaad.2018.03.004. (Epub 2018 Mar 12. PMID: 29544742)

    Article  PubMed  Google Scholar 

  5. Alghanem N, Abokwidir M, Fleischer AB Jr., Feldman SR, Alghanem W (2017) Variation in cash price of the generic medications most prescribed by dermatologists in pharmacies across the United States. J Dermatolog Treat 28(2):119–128. https://doi.org/10.1080/09546634.2016.1182614. (Epub 2016 May 31. PMID: 27241622)

    Article  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. College of Medicine, University of Florida, Gainesville, FL, USA

    Michael Joseph Diaz

  2. School of Medicine, Indiana University, Indianapolis, IN, USA

    Jasmine Thuy Tran

  3. Department of Dermatology, University of Florida, Gainesville, FL, USA

    Mahtab Forouzandeh

Authors
  1. Michael Joseph Diaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jasmine Thuy Tran
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mahtab Forouzandeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MJD and JTT wrote the main manuscript text and prepared tables 1,2. All authors reviewed the manuscript.

Corresponding author

Correspondence to Michael Joseph Diaz.

Ethics declarations

Conflict of interest

None.

IRB approval

Exempt.

Patient consent

N/A.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Diaz, M.J., Tran, J.T. & Forouzandeh, M. State laws and prescribing rates of generic drugs in dermatology: a cross-sectional analysis of 2020 Medicare Part D claims data. Arch Dermatol Res 315, 2991–2993 (2023). https://doi.org/10.1007/s00403-023-02719-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-023-02719-x

Keywords

Search

Navigation